Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-15

Clinical Trial Update: A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

View source ↗

Summary

A completed post-marketing surveillance study of etanercept (Enbrel) evaluating its real-world use in rheumatoid arthritis and psoriatic arthritis, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2013-08-15